Aptorum Group Limited's short interest decreased by 58.4% to 41,000 shares by April 15th.
Aptorum Group Limited (NASDAQ: APM) reports a 58.4% decrease in short interest to 41,000 shares by April 15th, down from 98,500 shares on March 31st, with a current days-to-cover ratio at 0.0 days. The biopharmaceutical company specializes in developing treatments for infectious diseases and cancer, including products like SACT-1, SACT-COV19, ALS-4, and ALS-1. Stock price fell to $5.28 on April 15th, while trading volume was lower than average at 27,222 shares.
April 27, 2024
3 Articles